Miruvor
Sign up
ME/CFS Moderate → relapsed

At 40-50% of normal with ME/CFS, improved then relapsed after Efgartigimod

Condition
ME/CFS
At worst
Moderate (mostly housebound)
Ill before improving or writing
Not stated
Last post
Nov 2025
In their words
  • Condition: ME/CFSI was able to spend the whole day at the zoo with my family without debilitating PEM or adrenaline dumps at night In context ↗
  • At worst: ModerateMaybe 40-50% to 85-90%. In context ↗
  • Now: RelapsedTook about 2-3 months to kick in and then another 2-3 months to wear off completely after our infusions stopped. In context ↗
Read from 4 of their posts and comments; links to the 2 this page draws on

Request to remove this story

Summary

Cedar 34104 took part in an Efgartigimod trial, including an open-label extension, going from about 40-50% of normal to 85-90%: able to work, spend a whole day at the zoo without PEM, with fewer POTS headaches. Improvement took two to three months and wore off completely two to three months after infusions stopped, and they sometimes cannot brush their teeth.

Ask Miruvor AI

Asking aboutCedar 34104’s story

What they tried

Their words about each treatment
  • Efgartigimod · Helped a lotMaybe 40-50% to 85-90%. Took about 2-3 months to kick in and then another 2-3 months to wear off completely after our infusions stopped. In context ↗

Approaches: Biologics & antibodies

Their path

Very severeSevereModerateMildNear normalRecovered

How ill they were on the ME/CFS severity scale, estimated from what they describe at each point, in the order they describe; they don’t give enough times to place each step. Hover or tap a point. Dates are when they posted. What the levels mean.

Show as a table
WhenWhat happenedWhere they wereAfter
—baseline before the Efgartigimod trialMaybe 40-50% to 85-90%. In context ↗Moderate
during the Efgartigimod trialsignificant improvement during open-label Efgartigimod trialI was able to spend the whole day at the zoo with my family without debilitating PEM or adrenaline dumps at night, able to work and brain functioning for my job, less POTS headaches. In context ↗Near normalEfgartigimod / Vyvgart
—benefit wore off after infusions stoppedanother 2-3 months to wear off completely after our infusions stopped In context ↗Moderate

Symptoms mentioned

Their words about their symptoms
  • Post-exertional malaisewithout debilitating PEM or adrenaline dumps at night In context ↗
  • POTS & dysautonomiaThey didn't consider our lab results or tilt tables (mine and others were resulting negative for POTS after being on the treatment) In context ↗
  • Headaches & migraineless POTS headaches In context ↗
  • Brain fogable to work and brain functioning for my job In context ↗

Ask Miruvor AI

Asking aboutCedar 34104’s story

Similar stories

  • Severe ME/CFS, largely in bed, now somewhat better with pacing and low-dose naltrexone

    Somewhat better Tide 39625 ME/CFS Severe at worstIll 23 months before improving or writing reddit.com Jul 2026

    A nurse who caught COVID in March 2021, she paced back to about 80% within five months, then part-time nursing pushed her to severe ME/CFS and she spent 2022 largely in bed. Over the following years she improved slowly to moderate, crediting pacing, low-dose…

  • Housebound with long COVID, now nearly back to normal after Vyvgart trial and ivabradine

    Near normal Creek 39914 Long COVID Severe at worstIll 4 years before improving or writing reddit.com Jul 2026

    Creek 39914 fell ill with COVID and by 2023 was housebound, walking about 2,000 steps a day and crashing from reading. They credit the Vyvgart (efgartigimod) trial and ivabradine with returning to full-time work and walking 6,000 steps. After the trial…

  • Vyvgart brought us back to life (Clare)

    Relapsed Long COVID Moderate at worst thesicktimes.org Oct 2025

    Clare, a nurse who was unable to work with Long COVID, joined a Vyvgart (efgartigimod) trial in 2023. She experienced major symptom relief, with her tachycardia significantly improved and her post-exertional malaise lessened, though not a full return to…

  • Not enough detail to draw a path

    Vyvgart brought us back to life (Michaelene)

    Relapsed Long COVID thesicktimes.org Oct 2025

    Michaelene took Vyvgart (efgartigimod), an infusion given weekly, for five months in the open-label phase of a Long COVID POTS trial. Michaelene reported no longer meeting criteria for POTS when the trial was abruptly canceled. Once the drug stopped, the…

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime